| Trial ID: | L1332 |
| Source ID: | NCT00448071
|
| Associated Drug: |
Mtr107
|
| Title: |
Pharmacokinetic and Pharmacodynamic Effects of MTR107 in End-Stage Renal Disease (ESRD) Patients
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Hypotension|End Stage Renal Disease|Intra Dialytic Hypotension
|
| Interventions: |
DRUG: MTR107
|
| Outcome Measures: |
Primary: A descriptive pharmacokinetic / pharmacodynamic study. No primary end-points apply. | Secondary: Exploratory Efficacy Parameters:| Number and type of medical interventions required for treatment of hypotension.| Alleviation of symptoms associated with intradialytic hypotension.| Efficiency of dialysis as reflected by Kt/V
|
| Sponsor/Collaborators: |
Sponsor: Wolfson Medical Center | Collaborators: Meditor Pharmaceuticals Ltd.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
12
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-05
|
| Completion Date: |
2007-03
|
| Results First Posted: |
|
| Last Update Posted: |
2007-03-15
|
| Locations: |
Wolfson Medical Center, Holon, 58100, Israel|Asaf Harofeh Medical Center, Rishon Le Zion, 70300, Israel
|
| URL: |
https://clinicaltrials.gov/show/NCT00448071
|
